Drug Testing Locations - West Burlington, IA

Drug Testing in West Burlington, IA

West Burlington, Iowa Statistics

In 2021, Des Moines County reported a drug-related death rate of 13.5 per 100,000 people.

In West Burlington, IA, 18% of high school students admitted to using marijuana in 2020.

The emergency department at Great River Medical Center in Des Moines County saw a 9% increase in drug overdose cases in 2022.

In 2021, 25% of drug-related arrests in Des Moines County involved methamphetamine.

Des Moines County's opioid prescription rate was 78.5 per 100 individuals in 2020, higher than the state average.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in West Burlington, IA & Drug Testing Policies

In West Burlington, IA, employers are increasingly incorporating drug testing policies to ensure a safe and productive work environment. Pre-employment screenings, as well as random drug tests, are common in industries such as manufacturing and transportation. These practices are in line with state guidelines and often overseen by human resources departments.

Employers also focus on providing support for employees battling addiction, often offering counseling services and assistance programs. For more information, businesses can refer to resources from the U.S. Equal Employment Opportunity Commission (EEOC) regarding legal guidelines and discrimination prevention related to drug use.

Government Efforts with Drug Problems in West Burlington, IA

The government of West Burlington, IA, alongside Des Moines County, has been actively working to curb drug abuse. The local police department collaborates with state agencies to monitor and reduce drug trafficking activities. Various awareness campaigns, conducted in schools and community centers, focus on educating citizens about the risks of drug abuse.

The state also supports rehabilitation programs and provides resources for families affected by substance abuse. The Iowa Office of Drug Control Policy (ODCP) is instrumental in coordinating these efforts and offers various initiatives and funding opportunities to enhance community safety and health.

Local Drug Busts & News in West Burlington, IA

Recently, West Burlington, IA, has seen several notable drug busts that highlight ongoing efforts to combat drug trafficking. In 2022, local law enforcement, in coordination with federal agencies, seized a substantial amount of methamphetamine from a residence in Des Moines County, leading to multiple arrests.

Another significant incident involved the dismantling of an opioid distribution ring in early 2023. These events showcase the strategic operations undertaken by local police to address drug-related crimes and maintain public safety. The collaboration between local and state law enforcement continues to be pivotal in reducing drug-related issues in the community.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in West Burlington, IA. Trusted by employers nationwide for accurate results and exceptional service.

Iowa DOT/Non DOT Physicals

Iowa Vision Tests

Iowa Audiograms

Iowa Respirator Fit Tests

Iowa Lift Tests

Iowa Background Checks

Clinical Testing Services

TB Testing in IA

Diabetes Testing in IA

Infectious Disease Testing in IA

Sickle Cell Anemia Testing in IA

Women/Men's Health Testing in IA

Resources & Citations

Iowa Harm Reduction Coalition

Area Substance Abuse Council

Iowa Latino Alliance

EyesOpenIowa

New Opportunities

Prevention Means Progress

Riverside Family Therapy

Tobacco Use Prevention & Control

Planned Parenthood of the Heartland

O'Connor Pharmacy

Drug Testing Near West Burlington, IA

West Point, IA

Fort Madison, IA

Yarmouth, IA

New London, IA

Mediapolis, IA

Denmark, IA

Wever, IA

Danville, IA

Patterson, IA

Middletown, IA

Beaverdale, IA

Burlington, IA

Frequently Asked Questions

Customer Reviews